Viking Therapeutics, Inc. (VKTX) annual balance sheet — 14-year assets, liabilities & equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|
| Total Current Assets | 608.21M | 715.6M | 907.22M | 367.23M | 167.04M | 210.53M | 256.1M | 283.5M | 302.13M | 21.85M | 13.97M | 15.2M | 773.68K | 179.62K | 0 |
| Cash & Short-Term Investments | 602.96M | 705.74M | 902.61M | 362.08M | 155.49M | 202.1M | 248.39M | 275.64M | 301.52M | 20.58M | 13.15M | 14.1M | 755.86K | 179.62K | 0 |
| Cash Only | 118.12M | 165.81M | 26.68M | 55.52M | 36.63M | 26.37M | 29.12M | 8.38M | 24.78M | 8.99M | 3.08M | 768.55K | 755.86K | 179.62K | 0 |
| Short-Term Investments | 484.85M | 539.93M | 875.94M | 306.56M | 118.85M | 175.73M | 219.27M | 267.26M | 276.74M | 11.59M | 10.08M | 13.34M | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.22M | 9.86M | 1.13M | 2.52M | 8.14M | 7.81M | 7.28M | 7.46M | 0 | 388.97K | 824.27K | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 33K | 131K | 1.1M | 1.26M | 1.49M | 134K | 399K | 755K | 179K | 269.61K | 560.88K | 237.46K | 2.27M | 775 | 0 |
| Property, Plant & Equipment | 0 | 85K | 1M | 1.13M | 1.42M | 25K | 321K | 598K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | 0.00x | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 33K | 46K | 102K | 139K | 71K | 109K | 78K | 157K | 179K | 269.61K | 560.88K | 237.46K | 2.27M | 775 | 0 |
| Total Assets | 608.24M | 715.73M | 908.32M | 368.49M | 168.53M | 210.66M | 256.5M | 284.26M | 302.31M | 22.12M | 14.54M | 15.44M | 3.04M | 180.39K | 0 |
| Asset Turnover | 0.00x | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -84.78% | -21.2% | 146.5% | 118.65% | -20% | -17.87% | -9.76% | -5.97% | 1266.6% | 52.19% | -5.85% | 407.34% | 1586.94% | - | - |
| Total Current Liabilities | 106.33M | 76.67M | 27.41M | 19.14M | 21.95M | 8.78M | 12.13M | 6.78M | 4.55M | 8.66M | 6.48M | 1.98M | 22.52M | 127.49K | 54.38K |
| Accounts Payable | 67.18M | 53.25M | 9.81M | 7.51M | 8.53M | 1.44M | 3.99M | 2.43M | 959K | 1.53M | 1.2M | 592.41K | 1.83M | 73.38K | 54.03K |
| Days Payables Outstanding | 57.18K | 45.1K | - | - | - | - | - | 3.41K | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.45M | 3.27M | 0 | 304.27K | 46.89K | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.28M | 1.27M | 0 | 20.32M | 0 | 0 |
| Other Current Liabilities | 39.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.4M | 731.05K | 0 | 58.74K | 0 | 0 |
| Current Ratio | 5.72x | 9.33x | 33.09x | 19.19x | 7.61x | 23.98x | 21.11x | 41.83x | 66.40x | 2.52x | 2.16x | 7.69x | 0.03x | 1.41x | - |
| Quick Ratio | 5.72x | 9.33x | 33.09x | 19.19x | 7.61x | 23.98x | 21.11x | 41.83x | 66.40x | 2.52x | 2.16x | 7.69x | 0.03x | 1.41x | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 630K | 936K | 1.26M | 0 | 29K | 360K | 12K | 4.98M | 16.31K | 4.74M | 2.65M | 303.51K | 51.04K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.15M | 1.26M | 231.85K | 42.75K |
| Capital Lease Obligations | 728K | 0 | 630K | 936K | 1.26M | 0 | 29K | 360K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12K | 0 | 16.31K | 2.59M | 1.39M | 71.66K | 8.29K |
| Total Liabilities | 106.33M | 76.67M | 28.04M | 20.07M | 23.21M | 8.78M | 12.16M | 7.14M | 4.56M | 8.66M | 6.49M | 6.71M | 25.17M | 431K | 105.42K |
| Total Debt | 0 | 137K | 1.12M | 1.26M | 1.56M | 29K | 359K | 662K | 0 | 3.45M | 3.27M | 2.15M | 1.57M | 278.75K | 42.75K |
| Net Debt | -118.12M | -165.67M | -25.56M | -54.26M | -35.07M | -26.34M | -28.76M | -7.71M | -24.78M | -5.54M | 194.08K | 1.38M | 812.53K | 99.13K | 42.75K |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | - | 0.26x | 0.41x | 0.25x | - | - | - |
| Debt / EBITDA | -0.00x | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 0.24x | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -15687.44x | -7023.96x | -1605.54x | -1145.76x | -1192.46x | -3093.44x | -371.59x | -175.57x | -38.26x | -9.55x | -6.25x | -21.98x | -37.33x | -4.96x | - |
| Total Equity | 501.92M | 639.06M | 880.28M | 348.42M | 145.32M | 201.88M | 244.34M | 277.12M | 297.75M | 13.46M | 8.04M | 8.72M | -22.13M | -250.6K | -105.42K |
| Equity Growth % | -103.54% | -27.4% | 152.65% | 139.76% | -28.02% | -17.38% | -11.83% | -6.93% | 2111.32% | 67.41% | -7.82% | 139.43% | -8730.08% | -137.73% | - |
| Book Value per Share | 4.34 | 5.67 | 8.07 | 3.69 | 1.89 | 2.62 | 3.37 | 3.85 | 5.17 | 0.52 | 0.49 | 1.37 | -5.13 | -0.06 | -71.10 |
| Total Shareholders' Equity | 501.92M | 639.06M | 880.28M | 348.42M | 145.32M | 201.88M | 244.34M | 277.12M | 297.75M | 13.46M | 8.04M | 8.72M | -22.13M | -250.6K | -105.42K |
| Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 358 | 208 | 97 | 60 | 52 | 50 |
| Retained Earnings | -1.01B | -847.55M | -487.91M | -377.94M | -292.05M | -223.18M | -168.19M | -128.7M | -102.92M | -80.85M | -60.28M | -45.55M | -22.14M | -257.27K | -111.03K |
| Treasury Stock | 0 | 0 | 0 | -6.79M | -6.79M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -856K | 378K | -788K | -389K | -1.1M | -549K | -54K | 12K | -423K | -19.77K | -6.89K | -7.37K | 0 | -4.5K | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying VKTX stock.
As of 2025, Viking Therapeutics, Inc. (VKTX) had total assets of $715.7M including $715.6M in current assets.
Viking Therapeutics, Inc. (VKTX) carries total debt of $0.1M, offset by $705.7M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Viking Therapeutics, Inc. (VKTX) has total shareholders' equity (book value) of $639.1M ($5.67 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Viking Therapeutics, Inc. (VKTX) reported a current ratio of 9.33x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.